PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Molecular Biology, Keio University School of Medicine, Tokyo, Japan.\', \'Department of Infection Biology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan; Transborder Medical Research Center, University of Tsukuba, Tsukuba, Japan; Microbiology Research Center for Sustainability, University of Tsukuba, Tsukuba, Japan.\', \'Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.\', \'Department of Infection Biology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.\', \'Department of Molecular Biology, Yokohama City University School of Medicine, Yokohama, Japan.\', \'Department of Molecular Biology, Keio University School of Medicine, Tokyo, Japan. Electronic address: awa403@keio.jp.\', \'Department of Molecular Biology, Keio University School of Medicine, Tokyo, Japan. Electronic address: kmurano@keio.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0021-9258(21)00118-610.1016/j.jbc.2021.100346
?:doi
?:hasPublicationType
?:journal
  • The Journal of biological chemistry
is ?:pmid of
?:pmid
?:pmid
  • 33524396
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Potent mouse monoclonal antibodies that block SARS-CoV-2 infection.
?:type

Metadata

Anon_0  
expand all